SG Americas Securities LLC Grows Holdings in SPDR S&P Biotech ETF $XBI

SG Americas Securities LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 41.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 391,243 shares of the exchange traded fund’s stock after buying an additional 114,638 shares during the quarter. SG Americas Securities LLC owned approximately 0.61% of SPDR S&P Biotech ETF worth $49,973,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $27,000. Intesa Sanpaolo Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $30,000. SHP Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $31,000. Legacy Wealth Managment LLC ID acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $32,000. Finally, Smartleaf Asset Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $32,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $145.86 on Tuesday. The stock has a market capitalization of $9.31 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a one year low of $80.90 and a one year high of $146.77. The company’s 50-day simple moving average is $133.84 and its 200-day simple moving average is $127.95.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.